Gut Microbiota and Aging: Traditional Chinese Medicine and Modern Medicine
- PMID: 37351381
- PMCID: PMC10284159
- DOI: 10.2147/CIA.S414714
Gut Microbiota and Aging: Traditional Chinese Medicine and Modern Medicine
Abstract
The changing composition of gut microbiota, much like aging, accompanies people throughout their lives, and the inextricable relationship between both has recently attracted extensive attention as well. Modern medical research has revealed that a series of changes in gut microbiota are involved in the aging process of organisms, which may be because gut microbiota modulates aging-related changes related to innate immunity and cognitive function. At present, there is no definite and effective method to delay aging. However, Nobel laureate Tu Youyou's research on artemisinin has inspired researchers to study the importance of Traditional Chinese Medicine (TCM). TCM, as an ancient alternative medicine, has unique advantages in preventive health care and in treating diseases as it already has formed an independent understanding of the aging system. TCM practitioners believe that the mechanism of aging is mainly deficiency, and pathological states such as blood stasis, qi stagnation and phlegm coagulation can exacerbate the process of aging, which involves a series of organs, including the brain, kidney, heart, liver and spleen. Our current understanding of aging has led us to realise that TCM can indeed make some beneficial changes, such as the improvement of cognitive impairment. However, due to the multi-component and multi-target nature of TCM, the exploration of its mechanism of action has become extremely complex. While analysing the relationship between gut microbiota and aging, this review explores the similarities and differences in treatment methods and mechanisms between TCM and Modern Medicine, in order to explore a new approach that combines TCM and Modern Medicine to regulate gut microbiota, improve immunity and delay aging.
Keywords: aging; gut microbiota; microbiota-gut-brain axis; traditional Chinese medicine.
© 2023 Li et al.
Conflict of interest statement
The authors report no conflicts of interest in this work.
Figures
Similar articles
-
Traditional Chinese Medicine for Alzheimer's Disease and Other Cognitive Impairment: A Review.Am J Chin Med. 2020;48(3):487-511. doi: 10.1142/S0192415X20500251. Epub 2020 Apr 24. Am J Chin Med. 2020. PMID: 32329645 Review.
-
The linkage of gut microbiota and the property theory of traditional Chinese medicine (TCM): Cold-natured and sweet-flavored TCMs as an example.J Ethnopharmacol. 2023 Apr 24;306:116167. doi: 10.1016/j.jep.2023.116167. Epub 2023 Jan 11. J Ethnopharmacol. 2023. PMID: 36641107 Review.
-
Traditional Chinese herbal formulas modulate gut microbiome and improve insomnia in patients with distinct syndrome types: insights from an interventional clinical study.Front Cell Infect Microbiol. 2024 May 16;14:1395267. doi: 10.3389/fcimb.2024.1395267. eCollection 2024. Front Cell Infect Microbiol. 2024. PMID: 38817449 Free PMC article.
-
From ancient wisdom to modern science: Gut microbiota sheds light on property theory of traditional Chinese medicine.J Integr Med. 2024 Jul;22(4):413-444. doi: 10.1016/j.joim.2024.06.001. Epub 2024 Jun 13. J Integr Med. 2024. PMID: 38937158 Review.
-
Gut microbiota modulation with traditional Chinese medicine: A system biology-driven approach.Pharmacol Res. 2019 Oct;148:104453. doi: 10.1016/j.phrs.2019.104453. Epub 2019 Sep 18. Pharmacol Res. 2019. PMID: 31541688 Review.
Cited by
-
Kangxianling formula attenuates renal fibrosis by regulating gut microbiota.Eur J Med Res. 2024 Mar 18;29(1):183. doi: 10.1186/s40001-024-01778-8. Eur J Med Res. 2024. PMID: 38500195 Free PMC article.
-
Network pharmacology and experimental validation to explore the pharmacological mechanism of saw palmetto and its core ingredients in benign prostatic hyperplasia treatment.Naunyn Schmiedebergs Arch Pharmacol. 2024 Jul 17. doi: 10.1007/s00210-024-03289-z. Online ahead of print. Naunyn Schmiedebergs Arch Pharmacol. 2024. PMID: 39017714
-
Compound Chinese medicine (F1) improves spleen deficiency diarrhea by protecting the intestinal mucosa and regulating the intestinal flora.Front Microbiol. 2024 Jan 16;14:1292082. doi: 10.3389/fmicb.2023.1292082. eCollection 2023. Front Microbiol. 2024. PMID: 38293559 Free PMC article.
-
Gut aging: A wane from the normal to repercussion and gerotherapeutic strategies.Heliyon. 2024 Sep 12;10(19):e37883. doi: 10.1016/j.heliyon.2024.e37883. eCollection 2024 Oct 15. Heliyon. 2024. PMID: 39381110 Free PMC article. Review.
-
Approach to the diagnosis and management of dysbiosis.Front Nutr. 2024 Apr 19;11:1330903. doi: 10.3389/fnut.2024.1330903. eCollection 2024. Front Nutr. 2024. PMID: 38706561 Free PMC article. Review.
References
-
- WHO. Maximizing potential of traditional medicines through modern science and technology; 2022. Available from: https://www.who.int/zh/news/item/25-03-2022-who-establishes-The-global-c.... Accessed June 12, 2023.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources